Shree Ganesh Remedies Ltd. | Small-cap | Healthcare
₹500.25
-2.37%
| Shree Ganesh Stock Comparison:
Shree Ganesh vs Sun PharmaceuticalShree Ganesh vs Divi's LaboratoriesShree Ganesh vs Innova CaptabShree Ganesh vs Suven Life SciencesShree Ganesh vs Aarti DrugsShree Ganesh vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 246.7M
Gross Profit 159.4M 64.62%
Operating Income 48.8M 19.77%
Net Income 34.5M 13.97%
EPS (Diluted) ₹2.68

Balance Sheet Metrics

Total Assets 1.9B
Total Liabilities 467.9M
Shareholders Equity 1.5B
Debt to Equity 0.32

Cash Flow Metrics

Revenue & Profitability Trend

Shree Ganesh Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue i 1.1B 1.3B 902.2M 712.9M 490.8M
Cost of Goods Sold i 361.7M 584.8M 471.6M 370.5M 220.2M
Gross Profit i 703.3M 674.2M 430.6M 342.4M 270.6M
Gross Margin % i 66.0% 53.6% 47.7% 48.0% 55.1%
Operating Expenses
Research & Development i 2.6M 235.0K - - -
Selling, General & Administrative i 28.6M 22.9M 18.7M 9.0M 8.0M
Other Operating Expenses i 175.3M 128.1M 88.2M 81.3M 50.6M
Total Operating Expenses i 206.5M 151.2M 106.9M 90.3M 58.7M
Operating Income i 301.9M 357.0M 203.1M 151.0M 112.6M
Operating Margin % i 28.3% 28.4% 22.5% 21.2% 22.9%
Non-Operating Items
Interest Income i 188.0K 646.0K 1.3M 1.5M 1.6M
Interest Expense i 20.1M 5.5M 446.0K 1.0M 304.0K
Other Non-Operating Income - - - - -
Pre-tax Income i 312.7M 381.6M 225.8M 180.1M 129.5M
Income Tax i 82.0M 100.5M 55.6M 46.1M 32.0M
Effective Tax Rate % i 26.2% 26.3% 24.6% 25.6% 24.7%
Net Income i 230.7M 281.1M 170.2M 134.0M 97.5M
Net Margin % i 21.7% 22.3% 18.9% 18.8% 19.9%
Key Metrics
EBITDA i 420.8M 445.8M 265.4M 213.0M 157.1M
EPS (Basic) i ₹17.96 ₹22.34 ₹14.01 ₹11.08 ₹9.68
EPS (Diluted) i ₹17.96 ₹22.34 ₹14.01 ₹11.08 ₹9.68
Basic Shares Outstanding i 12844836 12583000 12143896 12092667 10077452
Diluted Shares Outstanding i 12844836 12583000 12143896 12092667 10077452

Income Statement Trend

Shree Ganesh Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets
Cash & Equivalents i 99.4M 158.5M 86.5M 38.8M 34.7M
Short-term Investments i 182.8M 46.6M 25.0M - 31.2M
Accounts Receivable i 222.7M 203.3M 279.2M 183.8M 133.3M
Inventory i 220.2M 249.9M 181.8M 136.4M 127.1M
Other Current Assets 40.9M 1.0K - -1.0K 1.0K
Total Current Assets i 775.8M 702.0M 642.9M 449.1M 379.9M
Non-Current Assets
Property, Plant & Equipment i 31.6M 19.6M 13.1M 11.8M 22.4M
Goodwill i 4.7M 3.6M 7.4M 8.5M 11.7M
Intangible Assets i 4.7M 3.6M 3.6M 931.0K 445.0K
Long-term Investments - - - - -
Other Non-Current Assets -3.0K -1.0K 3.0K 500.0K 963.1K
Total Non-Current Assets i 1.1B 1.0B 795.4M 321.1M 226.1M
Total Assets i 1.9B 1.7B 1.4B 770.2M 606.0M
Liabilities
Current Liabilities
Accounts Payable i 59.7M 81.9M 145.3M 94.7M 62.1M
Short-term Debt i 87.8M 72.1M 25.8M - 2.1M
Current Portion of Long-term Debt - - - - -
Other Current Liabilities 1.7M -1.0K - - 415.0K
Total Current Liabilities i 161.8M 186.8M 237.4M 150.4M 101.9M
Non-Current Liabilities
Long-term Debt i 296.1M 292.4M 309.3M - -
Deferred Tax Liabilities i 5.3M 5.8M - 2.0M 2.4M
Other Non-Current Liabilities 10.0K - - - -1.0K
Total Non-Current Liabilities i 306.0M 301.6M 311.6M 4.0M 4.1M
Total Liabilities i 467.9M 488.4M 549.0M 154.4M 105.9M
Equity
Common Stock i 128.4M 128.4M 125.1M 120.1M 100.1M
Retained Earnings i 1.1B 867.2M 610.6M 447.2M 331.5M
Treasury Stock i - - - - -
Other Equity - - - - -
Total Shareholders Equity i 1.5B 1.2B 889.4M 615.7M 500.0M
Key Metrics
Total Debt i 383.8M 364.5M 335.1M 0 2.1M
Working Capital i 613.9M 515.2M 405.5M 298.7M 278.0M

Balance Sheet Composition

Shree Ganesh Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income i 312.7M 381.6M 225.8M 180.1M 129.5M
Depreciation & Amortization i - - - - -
Stock-Based Compensation i - - - - -
Working Capital Changes i 3.6M 16.9M -93.2M -87.0M -24.1M
Operating Cash Flow i 337.1M 403.9M 135.2M 36.8M -831.6K
Investing Activities
Capital Expenditures i -231.8M -311.3M -515.5M -153.3M -90.0K
Acquisitions i 0 - - - -172.0K
Investment Purchases i -128.3M -44.1M 0 -174.0K -10.0M
Investment Sales i 3.3M 24.8M 0 34.3M 840.0K
Investing Cash Flow i -356.8M -330.7M -535.7M -119.1M -8.6M
Financing Activities
Share Repurchases i - - - - -
Dividends Paid i - -6.3M -6.0M -16.1M -
Debt Issuance i - - - - -
Debt Repayment i - - - -788.0K -5.0M
Financing Cash Flow i 1.0K 67.4M 104.0M -10.9M -6.6M
Free Cash Flow i 74.7M -6.9M -345.7M -19.1M 33.0M
Net Change in Cash i -19.6M 140.6M -296.6M -93.2M -16.0M

Cash Flow Trend

Shree Ganesh Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 30.24
Price to Book 4.55
Price to Sales 6.08
PEG Ratio -1.16

Profitability Ratios

Profit Margin 20.16%
Operating Margin 19.77%
Return on Equity 15.89%
Return on Assets 12.02%

Financial Health

Current Ratio 4.79
Debt to Equity 26.44
Beta 0.12

Per Share Data

EPS (TTM) ₹17.00
Book Value per Share ₹113.00
Revenue per Share ₹84.44

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
sgrl 6.8B 30.24 4.55 15.89% 20.16% 26.44
Sun Pharmaceutical 4.0T 37.84 5.44 15.08% 19.29% 3.26
Divi's Laboratories 1.7T 70.61 10.85 14.64% 23.89% 0.03
Innova Captab 47.4B 36.47 4.94 13.37% 9.98% 35.24
Suven Life Sciences 47.4B -27.66 40.25 -146.15% 84.44% 0.00
Aarti Drugs 46.1B 24.56 3.38 12.28% 7.80% 44.92

Financial data is updated regularly. All figures are in the company's reporting currency.